Ticiana A. Leal, MD, medical oncologist, team leader, University of Wisconsin Carbone Cancer Center Thoracic Malignancies Disease Oriented Team, assistant professor, Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin School of Medicine and Public Health, discusses the rationale for the phase 2 ECOG-ACRIN EA5161 trial in extensive-stage small cell lung cancer (ES-SCLC).
Website: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
LinkedIn: [ Ссылка ]
